HCA Healthcare (HCA) to Release Quarterly Earnings on Friday

HCA Healthcare (NYSE:HCA) is projected to announce its Q1 2026 results before the market opens on Friday, April 24th. Analysts expect the company to announce earnings of $7.19 per share and revenue of $19.0861 billion for the quarter. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Investors can check the company’s upcoming Q1 2026 earning summary page for the latest details on the call scheduled for Friday, April 24, 2026 at 10:00 AM ET.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, beating the consensus estimate of $7.37 by $0.64. The company had revenue of $19.51 billion during the quarter, compared to the consensus estimate of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.HCA Healthcare’s revenue was up 6.7% on a year-over-year basis. During the same period in the previous year, the firm posted $6.22 EPS. On average, analysts expect HCA Healthcare to post $30 EPS for the current fiscal year and $33 EPS for the next fiscal year.

HCA Healthcare Stock Performance

Shares of HCA opened at $472.07 on Thursday. The stock has a fifty day moving average of $508.81 and a two-hundred day moving average of $485.14. The company has a market capitalization of $105.54 billion, a PE ratio of 16.63, a price-to-earnings-growth ratio of 1.45 and a beta of 1.36. HCA Healthcare has a fifty-two week low of $321.39 and a fifty-two week high of $556.52.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th were issued a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date was Tuesday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s payout ratio is currently 10.99%.

Analysts Set New Price Targets

A number of analysts have recently commented on the company. Wall Street Zen downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, February 14th. Oppenheimer upped their price objective on HCA Healthcare from $500.00 to $540.00 and gave the stock an “outperform” rating in a report on Wednesday, January 28th. Leerink Partners upped their price objective on HCA Healthcare from $507.00 to $573.00 and gave the stock an “outperform” rating in a report on Wednesday, January 28th. KeyCorp set a $503.00 price objective on HCA Healthcare in a report on Wednesday, January 28th. Finally, Robert W. Baird dropped their price objective on HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a report on Wednesday, April 15th. Sixteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $537.36.

Insider Buying and Selling at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 1,500 shares of the company’s stock in a transaction on Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total transaction of $747,135.00. Following the completion of the sale, the executive vice president directly owned 30,003 shares of the company’s stock, valued at approximately $14,944,194.27. This represents a 4.76% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Christopher F. Wyatt sold 4,000 shares of the company’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the completion of the transaction, the senior vice president directly owned 44,379 shares of the company’s stock, valued at approximately $22,411,395. The trade was a 8.27% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 15,214 shares of company stock valued at $7,797,595 in the last quarter. Company insiders own 1.50% of the company’s stock.

Hedge Funds Weigh In On HCA Healthcare

A number of institutional investors and hedge funds have recently added to or reduced their stakes in HCA. Viking Global Investors LP lifted its position in shares of HCA Healthcare by 58.5% during the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after purchasing an additional 690,773 shares during the last quarter. Zurich Insurance Group Ltd FI lifted its position in shares of HCA Healthcare by 3,755.9% during the third quarter. Zurich Insurance Group Ltd FI now owns 269,912 shares of the company’s stock worth $115,036,000 after purchasing an additional 262,912 shares during the last quarter. AQR Capital Management LLC lifted its position in shares of HCA Healthcare by 83.3% during the third quarter. AQR Capital Management LLC now owns 399,197 shares of the company’s stock worth $169,951,000 after purchasing an additional 181,464 shares during the last quarter. Corient Private Wealth LLC lifted its position in shares of HCA Healthcare by 421.4% during the fourth quarter. Corient Private Wealth LLC now owns 219,276 shares of the company’s stock worth $102,371,000 after purchasing an additional 177,223 shares during the last quarter. Finally, Abdiel Capital Advisors LP lifted its position in shares of HCA Healthcare by 35.5% during the second quarter. Abdiel Capital Advisors LP now owns 646,222 shares of the company’s stock worth $247,568,000 after purchasing an additional 169,201 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.